Announcements Trials

Browse Landscape

Phase

Phase 2 11 Phase 3 7 Phase 1 3 Phase NA 1 Phase 2/3 1 Phase 1/2 1

Status

Unknown 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1

Interventions

Blood Specimen Collection 104 Standard of Care 79 Exercise 67 Radiotherapy 53 Radiosurgery 48 Specimen Handling 45 Magnetic Resonance Spectroscopy 45 Surveys and Questionnaires 44 Interviews as Topic 44 Practice Guidelines as Topic 43 Educational Status 43 Methods 41 Drug Therapy 35 Early Intervention, Educational 30 Surgical Procedures, Operative 29 Palliative Care 25 Control Groups 25 Biopsy 24 Patient Navigation 18 venetoclax 17 Cisplatin 17 Therapeutics 16 Resistance Training 16 Proton Therapy 15 Magnetic Resonance Imaging 15 Behavior Therapy 15 Neoadjuvant Therapy 13 Cognitive Behavioral Therapy 13 Acupuncture Therapy 13 Nutritional Status 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recruiting × apalutamide × Clear all

NCT05649943 2025-09-03

APPROACH

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Recruiting

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡